Corrigendum to “Decreased ATM Protein Expression Is Substantiated with PTEN Loss in Defining Aggressive Phenotype of Prostate Cancer Associated with Lethal Disease” [Eur. Urol. Open Sci. 29 (2021) 93-101]

• Simon R. Walker,
• Ramy A. Abdelsalam,
• Sunita Ghosh,
• Julie Livingstone,
• Nallasivam Palanisamy,
• Paul C. Boutros,
• Steven M. Yip,
• Susan P. Lees-Miller,
• Tarek A. Bismar

Affiliations

Simon R. Walker

Department of Pathology and Laboratory Medicine, University of Calgary Cumming School of Medicine and Alberta Precision Laboratories, Calgary, AB, Canada

Ramy A. Abdelsalam

Department of Pathology and Laboratory Medicine, University of Calgary Cumming School of Medicine and Alberta Precision Laboratories, Calgary, AB, Canada; Department of Pathology, Faculty of Medicine, Mansoura University, Egypt, 35512 Mansoura, Egypt

Sunita Ghosh

Department of Medical Oncology, Faculty of Medicine and Dentistry, University of Alberta, and Alberta Health Services-Cancer Control, Edmonton, AB, Canada

Julie Livingstone

Departments of Human Genetics and Urology, University of California, Los Angeles, CA, USA

Nallasivam Palanisamy

Department of Urology, Vattikuti Urology Institute, Henry Ford Health System Detroit, MI, USA

Paul C. Boutros

Departments of Human Genetics and Urology, University of California, Los Angeles, CA, USA

Steven M. Yip

Tom Baker Cancer Centre, Calgary, AB, Canada

Susan P. Lees-Miller

Departments of Oncology, Biochemistry and Molecular Biology, University of Calgary Cumming School of Medicine, Calgary, AB, Canada; Arnie Charbonneau Cancer Institute, Calgary, AB, Canada

Tarek A. Bismar

Department of Pathology and Laboratory Medicine, University of Calgary Cumming School of Medicine and Alberta Precision Laboratories, Calgary, AB, Canada; Departments of Oncology, Biochemistry and Molecular Biology, University of Calgary Cumming School of Medicine, Calgary, AB, Canada; Arnie Charbonneau Cancer Institute, Calgary, AB, Canada; Corresponding author at: Departments of Pathology & Laboratory Medicine and Oncology, Rockyview General Hospital, Calgary, Alberta T2V 1P9, Canada. Tel. +1 (403) 943-8430; Fax: +1 (403) 943-3333.